Arax Advisory Partners’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53K Buy
5,412
+5,320
+5,783% +$52.5K ﹤0.01% 3218
2026
Q1
$895 Buy
92
+79
+608% +$724 ﹤0.01% 3324
2025
Q4
$124 Sell
13
-5,371
-100% -$54.7K ﹤0.01% 3796
2025
Q3
$52.5K Buy
+5,384
New +$41.4K ﹤0.01% 1812

Other funds holding PRTA

Arax Advisory Partners's PRTA Position: Q2 2026 in Review

Arax Advisory Partners increased its Prothena Corp (PRTA) stake by 5,783% in Q2 2026, buying an estimated $52.5K and bringing the position to 5,412 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #3218.

Arax Advisory Partners first reported a position in PRTA in Q3 2025 and has held it in 4 quarters since. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Arax Advisory Partners held 5,412 shares of Prothena Corp worth $53K as of Q2 2026.
  • Arax Advisory Partners bought 5,320 Prothena Corp shares in Q2 2026, an estimated $52.5K.
  • Prothena Corp made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3218 holding.
  • Arax Advisory Partners first reported a position in Prothena Corp in Q3 2025 and has held it in 4 quarters since.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.